530207 BRAWN

Brawn Biotech Share Price

₹24.01 -0.8 (-3.22%)

26 Dec, 2024 20:56

SIP TrendupStart SIP in BRAWN

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 12.25%
  • Over 3 Month + 23.32%
  • Over 6 Month -12.85%
  • Over 1 Year + 4.16%
SIP Lightning

Smart Investing Starts Here Start SIP with Brawn Biotech for Steady Growth!

Invest Now

Brawn Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Brawn Biotech Financials

Brawn Biotech Technicals

EMA & SMA

Current Price
₹24.01
-0.8 (-3.22%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹22.09
  • 50 Day
  • ₹21.48
  • 100 Day
  • ₹21.17
  • 200 Day
  • ₹20.71

Resistance and Support

24.84 Pivot Speed
  • R3 27.72
  • R2 26.88
  • R1 25.68
  • S1 23.64
  • S2 22.80
  • S3 21.60

What's your outlook on Brawn Biotech?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Brawn Biotech has an operating revenue of Rs. 13.65 Cr. on a trailing 12-month basis. An annual revenue de-growth of -25% needs improvement, Pre-tax margin of -9% needs improvement, ROE of -24% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Brawn Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results

Brawn Biotech F&O

Brawn Biotech Shareholding Pattern

53.64%
0.35%
33.84%
12.17%

About Brawn Biotech

  • NSE Symbol
  • BRAWN
  • BSE Symbol
  • 530207
  • ISIN
  • INE899B01015

Similar Stocks to Brawn Biotech

Brawn Biotech FAQs

Brawn Biotech share price is ₹24 As on 26 December, 2024 | 20:42

The Market Cap of Brawn Biotech is ₹7.2 Cr As on 26 December, 2024 | 20:42

The P/E ratio of Brawn Biotech is -4 As on 26 December, 2024 | 20:42

The PB ratio of Brawn Biotech is 1.4 As on 26 December, 2024 | 20:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23